FIELD: medicine.
SUBSTANCE: method includes introduction of dalargin, characterised by the fact that used is combination of peptides Gly-His-Lys and dalargin parenterally in equimolar single doses 0.5-1.2 mcg/kg of weight respectively one time per day, for ten days.
EFFECT: application of invention makes it possible to improve reparative ability of bone tissue and reduce terms of bone fracture consolidation.
4 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF OPIOID PEPTIDE DAGO FOR STIMULATION OF REPARATIVE OSTEOGENESIS IN LABORATORY ANIMALS | 2000 |
|
RU2195311C2 |
METHOD FOR OPTIMIZING REPARATIVE OSTEOGENESIS | 2006 |
|
RU2315580C2 |
METHOD FOR STIMULATING REPARATIVE OSTEOGENESIS AT EARLY STAGES OF POST-TRAUMATIC PERIOD | 2018 |
|
RU2676659C1 |
METHOD OF REPAIR OSTEOGENESIS STIMULATION IN TREATMENT OF FRACTURES | 2008 |
|
RU2364361C1 |
METHOD OF MODELLING STIMULATION OF REPARATIVE OSTEOGENESIS WITH EXTRACT OF FETAL BONE TISSUE CELLS | 2010 |
|
RU2433794C2 |
SOLID DOSAGE PHARMACEUTICAL COMPOSITION HAVING ABILITY TO REDUCE EXUDATION, PROVIDING FASTER WOUND CLEANSING FROM NECROTIC MASS, AS WELL AS PROVIDING FASTER EPITHELISATION AND REGENERATION | 2012 |
|
RU2488383C1 |
METHOD FOR FASTER FORMATION OF CALLUS IN MAMMALS | 2009 |
|
RU2404242C1 |
METHOD FOR STIMULATING FORMATION OF FIBROCARTILAGENOUS REGENERATED CLAVUS IN MAMMALS | 2011 |
|
RU2461621C1 |
METHOD FOR LENGTHENING PATIENT'S LIMBS | 2002 |
|
RU2235519C2 |
AGENT FOR STIMULATION OF REPARATIVE OSTEOGENESIS | 2015 |
|
RU2606257C1 |
Authors
Dates
2011-09-20—Published
2010-09-13—Filed